PL2155880T3 - Modyfikacja wytwarzania glikoproteiny w roślinach - Google Patents

Modyfikacja wytwarzania glikoproteiny w roślinach

Info

Publication number
PL2155880T3
PL2155880T3 PL08772802T PL08772802T PL2155880T3 PL 2155880 T3 PL2155880 T3 PL 2155880T3 PL 08772802 T PL08772802 T PL 08772802T PL 08772802 T PL08772802 T PL 08772802T PL 2155880 T3 PL2155880 T3 PL 2155880T3
Authority
PL
Poland
Prior art keywords
plants
glycoprotein production
modifying glycoprotein
modifying
production
Prior art date
Application number
PL08772802T
Other languages
English (en)
Inventor
Marc-Andre D'aoust
Estelle Marquet-Blouin
Muriel Bardor
Carole Burel
Loic Faye
Patrice Lerouge
Louis-Philippe Vezina
Véronique Gomord
Stéphanie Aquin
Christophe Rihouey
Thomas Paccalet
Christophe Sourrouille
Original Assignee
Medicago Inc.
Centre National De La Recherche Scientifique
Universite De Rouen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicago Inc., Centre National De La Recherche Scientifique, Universite De Rouen filed Critical Medicago Inc.
Publication of PL2155880T3 publication Critical patent/PL2155880T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
PL08772802T 2007-06-15 2008-06-13 Modyfikacja wytwarzania glikoproteiny w roślinach PL2155880T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94434407P 2007-06-15 2007-06-15

Publications (1)

Publication Number Publication Date
PL2155880T3 true PL2155880T3 (pl) 2017-06-30

Family

ID=40129187

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08772802T PL2155880T3 (pl) 2007-06-15 2008-06-13 Modyfikacja wytwarzania glikoproteiny w roślinach

Country Status (24)

Country Link
US (1) US20110008837A1 (pl)
EP (1) EP2155880B1 (pl)
JP (1) JP5783720B2 (pl)
KR (2) KR20130075787A (pl)
CN (3) CN101918559A (pl)
AU (1) AU2008261527C1 (pl)
BR (1) BRPI0812538B1 (pl)
CA (2) CA2795379A1 (pl)
DK (1) DK2155880T3 (pl)
EG (1) EG26600A (pl)
ES (1) ES2624776T3 (pl)
HU (1) HUE031698T2 (pl)
IL (1) IL202568A (pl)
MA (1) MA31516B1 (pl)
MX (1) MX2009013665A (pl)
NZ (2) NZ581944A (pl)
PL (1) PL2155880T3 (pl)
PT (1) PT2155880T (pl)
RU (2) RU2499053C2 (pl)
SG (1) SG185249A1 (pl)
SI (1) SI2155880T1 (pl)
TN (1) TN2009000512A1 (pl)
WO (1) WO2008151440A1 (pl)
ZA (1) ZA201000207B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
CN101978066A (zh) 2007-11-27 2011-02-16 麦迪卡格公司 表达血凝素之转基因植物中生产的重组流感病毒样颗粒(vlp)
CN105753948A (zh) 2008-07-08 2016-07-13 麦迪卡格公司 可溶性重组流感抗原
MX2011000657A (es) 2008-07-18 2011-03-21 Medicago Inc Epitopo de inmunizacion de nuevo virus de la influenza.
ES2669303T3 (es) 2009-06-24 2018-05-24 Medicago Inc. Partículas pseudovíricas quiméricas de influenza que comprenden hemaglutinina
BR112012006415B1 (pt) 2009-09-22 2020-04-28 Medicago Inc método para preparar vlps derivadas de plantas
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
EP2718444B1 (en) * 2011-06-07 2017-12-27 iBio, Inc. In vivo de-glycosylation of recombinant proteins by co-expression with pngase f
EP2551348B1 (en) 2011-07-29 2014-09-24 Icon Genetics GmbH Production of galactosylated N-glycans in plants
MX358883B (es) 2011-09-30 2018-08-31 Medicago Inc Aumentar el rendimiento de particulas similares a virus en plantas.
WO2013169009A1 (ko) * 2012-05-08 2013-11-14 경상대학교 산학협력단 고-만노오스형 n-글라이칸을 생산하는 식물체 및 이를 이용한 고-만노오스형 n-글라이칸의 생산방법
CN105247059B (zh) 2013-03-28 2021-07-06 莫迪卡戈公司 植物中流感样病毒颗粒的产生
EP3167057B1 (en) 2014-07-11 2020-03-25 Medicago Inc. Modifying protein production in plants
WO2016079739A2 (en) * 2014-11-20 2016-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
CA3045173A1 (en) 2016-12-01 2018-06-07 Plantform Corporation Transgenic plant with reduced fucosyltransferase and xylosyltransferase activity
WO2019049111A1 (en) * 2017-09-11 2019-03-14 R. J. Reynolds Tobacco Company METHODS AND COMPOSITIONS FOR INCREASING THE EXPRESSION OF GENES OF INTEREST IN A PLANT BY CO-EXPRESSION WITH P21
EP4265104A1 (en) * 2021-01-15 2023-10-25 Denka Company Limited Method for determining conditions for cultivation, and method for producing desired protein or desired peptide

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312746A (en) * 1993-01-08 1994-05-17 Life Technologies, Inc. Cloning and expressing restriction endonucleases and modification methylases from caryophanon
GB9524350D0 (en) * 1995-11-29 1996-01-31 Lynxvale Ltd Enhancer-increased gene expression in plants
US5945326A (en) * 1997-03-20 1999-08-31 New England Biolabs, Inc. Method for cloning and producing the Spel restriction endonuclease
PT1137789E (pt) * 1998-12-09 2010-10-21 Phyton Holdings Llc Um método para produzir glicoproteínas possuindo glicosilação de tipo humano
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
ES2254235T3 (es) * 1999-10-04 2006-06-16 Medicago Inc. Promotor para regular la expresion de genes foraneos.
EP1224309A2 (en) * 1999-10-21 2002-07-24 Monsanto Company Post-translational modification of recombinant proteins produced in plants
WO2001031044A1 (en) * 1999-10-26 2001-05-03 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Gonadotrophins in plants
BRPI0015031B1 (pt) * 1999-10-26 2017-05-30 Plant Res Int B V método para prover uma planta transgênica capaz de expressar um anticorpo com galactosilação terminal e método para obtenção de uma glicoproteína desejada ou fragmento funcional da mesma
US20040214273A1 (en) * 2001-01-19 2004-10-28 Kazuhito Fujiyama Method for secretory production of glycoprotein having human-type sugar chain using plant cell
US20030035774A1 (en) 2001-07-18 2003-02-20 Adjei Akwete L. Salt/ion pair medicinal aerosol formulation
NZ592087A (en) * 2001-08-03 2012-11-30 Roche Glycart Ag Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
KR101113432B1 (ko) * 2002-02-13 2012-02-29 위스콘신 얼럼나이 리서어치 화운데이션 인플루엔자 바이러스 벡터의 패키징을 위한 신호
EP2339004B1 (en) * 2002-03-19 2015-02-25 Stichting Dienst Landbouwkundig Onderzoek Optimizing glycan processing in plants
KR101070518B1 (ko) * 2002-03-19 2011-10-05 스티칭 디엔스트 랜드보위쿤디그 온데조에크 식물에서의 ｇｎｔⅲ 발현
ES2574993T3 (es) 2003-01-22 2016-06-23 Roche Glycart Ag Construcciones de fusión y uso de las mismas para producir anticuerpos con mayor afinidad de unión al receptor de Fc y función efectora
ES2349777T3 (es) * 2003-01-22 2011-01-11 Glycart Biotechnology Ag Constructos de fusión y uso de los mismos para producir anticuerpos con mayor afinidad de unión al receptor de fc y función efectora.
NZ543348A (en) * 2003-05-05 2008-08-29 Thompson Boyce Plant Res Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
JP2006212019A (ja) * 2004-04-30 2006-08-17 National Institute Of Agrobiological Sciences 植物を用いたユビキノン−１０の製造方法

Also Published As

Publication number Publication date
EP2155880A1 (en) 2010-02-24
CA2700180A1 (en) 2008-12-18
CA2700180C (en) 2013-01-29
AU2008261527B8 (en) 2014-04-24
CA2795379A1 (en) 2008-12-18
KR20100037602A (ko) 2010-04-09
KR101385050B1 (ko) 2014-05-13
WO2008151440A8 (en) 2010-03-04
EG26600A (en) 2014-03-23
NZ598417A (en) 2013-06-28
KR20130075787A (ko) 2013-07-05
CN104962579A (zh) 2015-10-07
SI2155880T1 (sl) 2017-03-31
WO2008151440A4 (en) 2009-02-26
RU2010101024A (ru) 2011-07-20
HUE031698T2 (en) 2017-07-28
SG185249A1 (en) 2012-11-29
NZ581944A (en) 2012-03-30
JP2010531136A (ja) 2010-09-24
IL202568A0 (en) 2011-08-01
BRPI0812538B1 (pt) 2021-03-16
AU2008261527C1 (en) 2014-09-04
EP2155880B1 (en) 2016-08-10
RU2499053C2 (ru) 2013-11-20
AU2008261527A8 (en) 2010-01-21
ES2624776T3 (es) 2017-07-17
IL202568A (en) 2015-02-26
PT2155880T (pt) 2016-11-18
ZA201000207B (en) 2013-09-25
MX2009013665A (es) 2010-06-02
US20110008837A1 (en) 2011-01-13
DK2155880T3 (en) 2016-12-05
BRPI0812538A2 (pt) 2014-09-30
WO2008151440A1 (en) 2008-12-18
AU2008261527B2 (en) 2014-04-10
MA31516B1 (fr) 2010-07-01
AU2008261527A1 (en) 2008-12-18
EP2155880A4 (en) 2010-08-04
JP5783720B2 (ja) 2015-09-24
CN103382487A (zh) 2013-11-06
CN101918559A (zh) 2010-12-15
TN2009000512A1 (en) 2011-03-31
RU2013137208A (ru) 2015-02-20

Similar Documents

Publication Publication Date Title
EG26600A (en) Modification of glycosyl properties at the -n position of glycoproteins produced in plants
EP2149625A4 (en) LOCAL INTEGRATED PRODUCTION PLANT
HK1136696A1 (en) Production
EP2222155A4 (en) ALGAE PRODUCTION
EP2501815A4 (en) BIGARRURE IN PLANTS
LT2339910T (lt) Šiltnamis
EP2239093A4 (en) PRODUCTION INSTALLATION
ZA201101587B (en) Salinity tolerance in plants
IL210667A0 (en) Change in plant architecture
ZA201000206B (en) Protein production in plants
AP2009004902A0 (en) Deep-shaft depurator plant comprising two air-lifts
PL1992760T3 (pl) Szklarnia
IL182171A0 (en) Energy production
GB0801506D0 (en) Enhanced plant growth
GB0718757D0 (en) Plant pot
EP2410177A4 (en) COMBINED SOLAR INSTALLATION WITH AIR-VAPOR TECHNOLOGY
GB0711529D0 (en) Oxygen plant
IL210501A0 (en) Plants producing 2n pollen
EP2140756A4 (en) POT
HU1000142V0 (en) Ornament
GB0715558D0 (en) Plant pot
PL383636A1 (pl) Łóżko-siłownia
GB0816050D0 (en) Plant technology
AU2007903720A0 (en) Polyhydroxyalkanoate production in plants
PL383524A1 (pl) Kruszarkownia